Total Company Value: nexalin.com (NXL)

Nexalin Technology, Inc. (NXL) develops non-invasive brain stimulation devices to help individuals manage anxiety and sleep disorders. This innovative approach enables the treatment of depression through physical stimulation, offering an alternative to medication in psychiatric centers. This price chart reflects an Enterprise Value of 0.71, while the rollout of new electrostimulator models in clinics drives the company's current growth.

Stable capacity utilization at Nexalin Technology, Inc. for the production of neurostimulators is reflected in the dynamics of the enterprise value. This indicator determines the real acquisition price of the business by combining market capitalization with net debt. The calculation is based on the sum of equity and liabilities minus liquid cash. Such a model allows market noise to be stripped away from the fundamental valuation of assets, which is critical for analyzing capital stability in the absence of production downtime.